Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review

Front Immunol. 2022 Dec 23:13:1019582. doi: 10.3389/fimmu.2022.1019582. eCollection 2022.

Abstract

Colorectal cancers (CRCs) with high microsatellite instability (MSI-H) and deficient mismatch repair (dMMR) show molecular and clinicopathological characteristics that differ from those of proficient mismatch repair/microsatellite stable CRCs. Despite the importance of MSI-H/dMMR status in clinical decision making, the testing rates for MSI and MMR in clinical practice remain low, even in high-risk populations. Additionally, the real-world prevalence of MSI-H/dMMR CRC may be lower than that reported in the literature. Insufficient MSI and MMR testing fails to identify patients with MSI-H/dMMR CRC, who could benefit from immunotherapy. In this article, we describe the current knowledge of the clinicopathological features, molecular landscape, and radiomic characteristics of MSI-H/dMMR CRCs. A better understanding of the importance of MMR/MSI status in the clinical characteristics and prognosis of CRC may help increase the rates of MMR/MSI testing and guide the development of more effective therapies based on the unique features of these tumors.

Keywords: characteristics; colorectal cancer; deficient mismatch repair; high microsatellite instability; microsatellite instability; prognosis; review; therapy development.

Publication types

  • Review

MeSH terms

  • Colonic Neoplasms*
  • Colorectal Neoplasms* / pathology
  • DNA Mismatch Repair / genetics
  • Humans
  • Microsatellite Instability
  • Prognosis